IL6 and colitis: 7-day long administration of 2.5% DSS to HFD-fed mice resulted in a distinct colitis phenotype at week 16th confirmed by an increase of DAI, IL-6 mRNA expression and MPO activity (see Additional file 1: Fig. S1).